Biodesix, Inc. (BDSX) vs Greenwich LifeSciences, Inc. (GLSI)
A side-by-side comparison of Biodesix, Inc. and Greenwich LifeSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$29.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GLSI
Greenwich LifeSciences, Inc.
$16.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BDSX vs GLSI
growth of $100 · dividends reinvested · last 6yBDSX -88.7% (-30.4%/yr)GLSI +316.5% (+26.8%/yr)GLSI compounded faster over this window
Log scale — wide-divergence pair
BDSX GLSI
BDSX vs GLSI: by the numbers
- •GLSI is the larger company ($248M vs $237M market cap).
- •Both run net losses; GLSI's is the smaller (0.00% vs -26.97% net margin).
Metrics side by side
Valuation
| Metric | BDSX | GLSI |
|---|---|---|
| P/S ratio | 2.30 | N/A |
| P/B ratio | 25.87 | 79.63 |
Profitability
| Metric | BDSX | GLSI |
|---|---|---|
| Gross margin | 82.50% | 0.00% |
| Operating margin | -31.37% | 0.00% |
| Net margin | -26.97% | 0.00% |
| ROE | -303.61% | -695.56% |
| ROIC | -25.73% | -701.55% |
Growth (annualized)
| Metric | BDSX | GLSI |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | N/A |
| Total return CAGR (5Y) | -28.49% | -14.84% |
Frequently asked
- How have BDSX and GLSI total returns compared?
- Over the past 5 years, BDSX delivered -28.49% and GLSI delivered -14.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.